69 Health Tech Startups in Cambridge to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Imaging analytics platform that processes and analyzes medical images. |
$8M · Series A | Ascension Ventures, Guinness Ventures, Hargreave Hale Aim VCT | 1 to 10 | Health Tech, Machine Learning, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@qureight.com | |
Industrial diagnostic testing platform. |
$2M · Seed | Innovate UK | 1 to 10 | Health Tech | B2B | Cambridge, UK | •••••••••••@fuse-dx.com | |
Surgical robotic system for minimal access surgery. |
$164M · Series D | SoftBank Group, Tencent, ABB Technology Ventures | 501 to 1000 | Health Tech, Robotics | B2B | Cambridge, UK | •••••••••••@cmrsurgical.com | |
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
AI platform to advance precision medicine clinical trials. |
$11M · Series A | Seedcamp, Plural, Episode 1 | 11 to 50 | Health Tech, Biotech | B2B, SaaS | Cambridge, UK | •••••••••••@sanogenetics.com | |
Small molecule neoantigen immuno-oncology therapies developer. |
$12M · Series B | Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management | 1 to 10 | Health Tech | Cambridge, UK | •••••••••••@neophore.com | ||
Human microbiome therapeutics developer creating live bacterial treatments and biomarkers. |
$66M | Seventure Partners, Cambridge Innovation Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Drug delivery platform. |
$24M · Series A | 4BIO Capital, UCB Ventures, Business Growth Fund | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@vianautis.com | ||
Platform for discovering new drugs for rare diseases using AI technology. |
$56M · Series B | Balderton Capital, Atomico, btov Partners | 51 to 100 | Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@healx.io | |
Medical technology improving breast cancer care through magnetic sensing innovations. |
$20M · Series D | Molten Ventures | 51 to 100 | Health Tech, Hardware | B2B | Cambridge, UK | •••••••••••@endomag.com | |
Platform enabling the development of cell therapies through advanced reprogramming techniques. |
$10M · Series A | Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
"Biotechnology platform producing sugar substitutes." |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Contract Research Organization specializing in bioscience research services. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
Genomics company building safer cell and gene therapies. |
$15M · Series A | Tencent, Illumina Ventures | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@brokenstringbio.com | ||
Physiological upregulation therapy to treat neurodegenerative diseases. |
$5M · Seed | SV Health Investors | 11 to 50 | Health Tech, Biotech | Cambridge, UK | •••••••••••@harnesstx.com | ||
Platform for understanding and defining the biological codes that make up human cells. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
AI-driven tech for respiratory conditions. |
$9M · Series A | Business Growth Fund, Downing Ventures | 11 to 50 | Health Tech, AI | Cambridge, UK | •••••••••••@tidalsense.com | ||
Fibroblast technology designed to develop new therapies for diseases. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
Precision software for surgeries. |
$11M · Series A | Pembroke VCT | 11 to 50 | Health Tech | B2B, SaaS | Cambridge, UK | •••••••••••@cydarmedical.com | |
Platform for helping people navigate end-of-life. |
$14M | Creandum, Headline | 1 to 10 | Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing | B2C | Cambridge, UK | •••••••••••@joincake.com | |
Drug manufacturer. |
$10M · Series A | Biospring Partners | 501 to 1000 | Health Tech, Biotech, Pharma | B2B, SaaS | Cambridge, UK | •••••••••••@abzena.com | |
Pharmacy service that combines caring customer support with modern technology for a personalized experience. |
$6M · Seed | Hoxton Ventures | 11 to 50 | Health Tech, CPG & Consumer Goods, Pharma, Ecommerce | B2B, B2C, SaaS | Cambridge, UK | •••••••••••@pillsorted.com | |
Pet therapeutics startup dedicated to developing medicines for pets. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Platform that helps manage and analyze life sciences data for organizations. |
$3M · Seed | ETF Partners, Granpool Innovative Investments | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@eaglegenomics.com | |
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
Deubiquitylating enzyme (DUB) drug discovery and development platform. |
$6M · Series A | Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments | 51 to 100 | Health Tech, Biotech | Cambridge, UK | •••••••••••@missiontherapeutics.com | ||
Cancer immunotherapeutics company working across the Atlantic. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Live human cell cultures and genome editing services for researchers. |
$5M | Calculus Capital | 11 to 50 | Health Tech, Biotech, Pharma, Business Intelligence | B2B | Cambridge, UK | •••••••••••@axolbio.com | |
Independent biotech company focused on developing new cancer therapies targeting DNA damage response. |
$152M · Series C | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@artiospharma.com | |||
Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw. |
$88M · Series D | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cambridge-epigenetix.com | |||
Breathalyzer technology for non-invasive detection of infectious diseases. |
$57M · Series D | 101 to 250 | Health Tech | Cambridge, UK | •••••••••••@owlstonemedical.com | |||
Platform utilizing microfabrication technology to create smart materials for innovative cell testing. |
$2M · Seed | Parkwalk Advisors, Martlet Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@semarion.com | |
Platform specializing in single cell analysis and characterization, offering related R&D services. |
$4M | Sofinnova Partners | 11 to 50 | Health Tech, Deep Tech | B2B | Cambridge, UK | •••••••••••@spherefluidics.com | |
Novel cancer therapies. |
$30M · Series B | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@stormtherapeutics.com | ||
Drug discovery company based in Cambridge, UK. |
$45M · Series B | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phoremost.com | |||
Clinical stage studies to discover biomarkers to improve medical diagnosis. |
$2M · Seed | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@upfrontdiagnostics.com | |||
Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC). |
$940k · Seed | Octopus Ventures, Longwall Venture, BlueYard Capital | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@biofidelity.com | |
Biopharmaceutical company focused on drug discovery and development for protein misfolding diseases. |
$16M | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@wrentherapeutics.com | |||
Platform for increasing protein production in the body using specialized translation enhancers. |
$12M · Seed | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@transinetx.com | ||
Wearable device that offers non-invasive medical technology. |
$692k · Pre Seed | Amadeus Capital, Parkwalk Advisors | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@charconeurotech.com | |
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery. |
$1M · Pre Seed | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@cardiatec.ai | ||
Smart pest control system provider. |
$1M · Seed | Martlet Capital | 1 to 10 | Health Tech, Manufacturing, Community & Lifestyle | B2C | Cambridge, UK | •••••••••••@spotta.co | |
Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services. |
$604k | Innovate UK | 11 to 50 | Health Tech | Cambridge, UK | •••••••••••@healthera.co.uk | ||
Platform technology overcoming antibacterial resistance. |
$9M | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phicotx.co.uk | |||
AI-powered mental health assessment platform. |
$5M · Series A | Parkwalk Advisors, Martlet Capital | 11 to 50 | Health Tech, AI | SaaS, B2C | Cambridge, UK | •••••••••••@psyomics.com | |
Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches. |
$18M | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Cambridge, UK | •••••••••••@nrgtherapeutics.com | ||
Treatment for patients with chronic wounds. |
$13M · Series B | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@solascure.com | |||
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis. |
$7M · Series A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@predictimmune.com | |||
Healthcare technology company improving patient care through innovative solutions. |
$2M | Health Tech | Cambridge, UK | •••••••••••@spirea.co.uk | ||||
Platform for life science professionals to connect with global experts for strategic engagement. |
$3M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@monocl.com | ||
Platform identifying chemical starting points to speed up drug discovery at lower costs. |
$2M · Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@pharmenable.com | ||
Diagnostic decision support platform for biotechnology applications. |
N/A | QVentures, Cambridge Innovation Capital, Parkwalk Advisors | 11 to 50 | Health Tech, Biotech, Genetics | B2B | Cambridge, UK | •••••••••••@congenica.com | |
AI extracting health data from sound. |
$585k · Pre Seed | 1 to 10 | Health Tech, Hardware, AI, Machine Learning, Manufacturing | B2B | Cambridge, UK | •••••••••••@decorte.co.uk | ||
Medical device-based system using AI to support clinical care for people with cancer. |
$1M · Seed | 1 to 10 | Health Tech, Hardware, AI, Manufacturing | B2B | Cambridge, UK | •••••••••••@52north.health | ||
A digital fertility clinic for men providing personalized care and services. |
N/A | 101 to 250 | Health Tech, Biotech, Proptech & Real Estate, Femtech, Mobile, Energy & Nuclear, Genetics, Business Intelligence, Fertility | B2B, SaaS | Cambridge, UK | •••••••••••@givelegacy.com | ||
Therapies designed to achieve long-term disease remission with less frequent doses. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@revolobio.com | |||
Molecular therapies for cancer patients. |
N/A | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@acaciapharma.com | ||
Supplier of protein research tools for scientific studies. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@antibodies.com | |||
Platform for creating next-generation biotherapeutics. |
N/A | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@bicycletherapeutics.com | |||
Platform offering precision oncology solutions to improve cancer treatment. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@ccg.ai | |||
Platform for developing proprietary drugs using VH antibody fragments. |
N/A | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@crescendobiologics.com | |||
Technology that advances genomics through innovative NGS techniques. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@csgenetics.com | |||
Human cell provider for drug discovery use in lead optimization and toxicity programs. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@definigen.com | |||
Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@elpis.ltd | |||
Biotech firm specializing in alternative splicing of VEGF for eye disease treatments. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@exonate.com | |||
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |
N/A | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@f-star.com | |||
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health. |
N/A | 251 to 500 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@horizondiscovery.com | |||
Platform that uses machine learning to improve healthcare data utilization. |
N/A | 11 to 50 | Health Tech, Data and Analytics | Cambridge, UK | •••••••••••@kirontech.com | |||
Lab 21 supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services. |
N/A | 51 to 100 | Health Tech | Cambridge, UK | •••••••••••@lab21.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.